RxDoctor Payments Data

Rohan Shah, MD

Retina Specialist · Hixson, TNNPI 1811139470

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Alcon at 42.2% of the total. 2024 is the largest year on record at $298, 5.1 times the $58 reported in 2019. That places this record below the midpoint for retina specialist clinicians in TN, where the typical reported total is $3,018.

$575in general payments, 2019–2025

Across 13 payments — averaging $44.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$243
  • Abbott$180
  • Lilly USA, LLC$59
  • OPKO Pharmaceuticals, LLC$40
  • Novartis$31
  • Biogen$24
$671,958in research payments, 2019–2025

Across 76 payments — averaging $8841.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$497K
  • Novartis$160K
  • Novo Nordisk AS$13K
  • AbbVie$3K

What the payments were for

  • Food & beverage$575100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alcon5$243
Abbott1$180
Lilly USA, LLC3$59
OPKO Pharmaceuticals, LLC1$40
Novartis2$31
Biogen1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$575 in reported general payments places this provider in the 5th percentile of 58 retina specialist providers in Tennessee.

See all retina specialist providers in Tennessee

Medicare billing

Part B allowed, 2024
$4,344,934
Medicare patients
908
Services billed
39,949

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate221$10,029
ProlensaBromfenac Sodium16$7,057
Bromfenac Sodium43$4,966
Ketorolac Tromethamine117$3,023
Brimonidine Tartrate49$1,860
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat70$1,357
ValacyclovirValacyclovir Hcl15$1,265
Atropine Sulfate18$807
Latanoprost50$612
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha56$594
Dorzolamide Hcl28$391
Timolol Maleate33$340
Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim26$188
MoxifloxacinMoxifloxacin Hcl17$162

Paid to pharmacies, not to this prescriber.

Other retina specialist in Hixson

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →